Drug-Induced Liver Disturbance During the Treatment of COVID-19
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have di...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_6e39d0f1fc084f589637e2b0bfd9cf46 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Guanghua Zhai |e author |
| 700 | 1 | 0 | |a Meifen Li |e author |
| 700 | 1 | 0 | |a Ying Wang |e author |
| 700 | 1 | 0 | |a Jian Wu |e author |
| 700 | 1 | 0 | |a Jian Wu |e author |
| 245 | 0 | 0 | |a Drug-Induced Liver Disturbance During the Treatment of COVID-19 |
| 260 | |b Frontiers Media S.A., |c 2021-08-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2021.719308 | ||
| 520 | |a An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have different degrees of liver disturbance. However, the relationship between the drugs used for COVID-19 treatment and liver disturbance remains controversial. It is essential to evaluate the potential liver damage caused by various drugs in order to help guide clinical practice. This review analyzed the effect of drugs on hepatic function during the treatment of COVID-19. | ||
| 546 | |a EN | ||
| 690 | |a severe acute respiratory syndrome coronavirus 2 | ||
| 690 | |a coronavirus disease 2019 | ||
| 690 | |a liver disturbance | ||
| 690 | |a drugs | ||
| 690 | |a treatment | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 12 (2021) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2021.719308/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/6e39d0f1fc084f589637e2b0bfd9cf46 |z Connect to this object online. |